Current role
Biotechnology · Healthcare
Chief Accounting Officer
2022-03-11–present
Gregory Tourangeau
Chief Accounting Officer
Fulcrum Therapeutics, Inc. (FULC)Equibles does not estimate personal net worth.
Get an email with a short summary when Fulcrum Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get FULC alertsAbout Gregory Tourangeau
Gregory Tourangeau is recorded as Chief Accounting Officer at Fulcrum Therapeutics, Inc. (FULC) since March 11, 2022. Fulcrum Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Fulcrum Therapeutics, Inc. includes Alex C. Sapir (CEO and Board Member), Bryan Stuart (CEO, COO and Board Member), Robert J. Gould (CEO) and 7 others.
Affiliation history
-
Current
2022-03-11–present
Company network
Leadership on record at Fulcrum Therapeutics, Inc.
- Alex C. Sapir CEO, Board Member
- Bryan Stuart CEO, COO, Board Member
- Robert J. Gould CEO
- Kate Haviland Chairman
- Mark Levin Chairman
- Alan A. Musso CFO
- Peter Thomson CFO
- Robert E. Gould CFO
- Mel Hayes COO
- Alan Musso Chief Accounting Officer
Recent activity
No call appearances or filed executive changes recorded yet.